Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature (Q36930855)

17 August 2017

1 reference

title

Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature (English)

1 reference

17 August 2017

1 reference

Staphylococcus aureus

1 reference

Andrew F Shorr

1

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

25

1 reference

17 August 2017

9

1 reference

17 August 2017

751-768

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200725090-00004

17 August 2017

0 references

cites work

The economic impact of Staphylococcus aureus infection in New York City hospitals

1 reference

12 December 2020

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

1 reference

12 December 2020

Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

1 reference

12 December 2020

Ventilator-associated pneumonia

1 reference

12 December 2020

Nosocomial pneumonia: a cost-of-illness analysis

1 reference

12 December 2020

The burden of diabetic foot ulcers

1 reference

12 December 2020

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

1 reference

12 December 2020

Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?

1 reference

12 December 2020

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.

1 reference

12 December 2020

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

12 December 2020

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control

1 reference

12 December 2020

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections

1 reference

12 December 2020

Postoperative bacteremia secondary to surgical site infection

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

1 reference

12 December 2020

Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors

1 reference

12 December 2020

Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals

1 reference

12 December 2020

Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections

1 reference

12 December 2020

Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment

1 reference

12 December 2020

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

12 December 2020

Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy

1 reference

12 December 2020

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

12 December 2020

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia

1 reference

12 December 2020

Hospital-acquired pneumonia: risk factors, microbiology, and treatment

1 reference

12 December 2020

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence

1 reference

12 December 2020

Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem

1 reference

12 December 2020

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

1 reference

12 December 2020

Preventing foot ulcers in patients with diabetes

1 reference

12 December 2020

Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections

1 reference

12 December 2020

Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

12 December 2020

Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients

1 reference

12 December 2020

Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A).

1 reference

12 December 2020

Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus

1 reference

12 December 2020

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

1 reference

12 December 2020

Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women

1 reference

12 December 2020

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains

1 reference

12 December 2020

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

1 reference

12 December 2020

Health-economic consequences of diabetic foot lesions

1 reference

12 December 2020

Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients

1 reference

12 December 2020

MRSA and osteomyelitis of the foot in diabetes

1 reference

12 December 2020

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

1 reference

12 December 2020

A U.S. population-based survey of Staphylococcus aureus colonization

1 reference

12 December 2020

Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobial

1 reference

12 December 2020

Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units

1 reference

12 December 2020

A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance

1 reference

12 December 2020

Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital.

1 reference

12 December 2020

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.

1 reference

12 December 2020

Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation

1 reference

12 December 2020

Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?

1 reference

12 December 2020

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

12 December 2020

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

1 reference

12 December 2020

Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections

1 reference

12 December 2020

Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model

1 reference

12 December 2020

Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey

1 reference

12 December 2020

Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain

1 reference

12 December 2020

Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model

1 reference

12 December 2020

Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci

1 reference

12 December 2020

The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations

1 reference

12 December 2020

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin

1 reference

12 December 2020

An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states

1 reference

12 December 2020

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

12 December 2020

The changing epidemiology of Staphylococcus aureus?

1 reference

12 December 2020

The global burden of diabetic foot disease

1 reference

12 December 2020

Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers

1 reference

12 December 2020

Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility

1 reference

12 December 2020

Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling

1 reference

12 December 2020

Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study

1 reference

12 December 2020

Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

1 reference

12 December 2020

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

12 December 2020

The growing menace of community-acquired methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

1 reference

12 December 2020

Management of healthcare-associated methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Additional Costs for Preventing the Spread of Methicillin-Resistant Staphylococcus aureus and a Strategy for Reducing These Costs on a Surgical Ward

1 reference

12 December 2020

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

1 reference

12 December 2020

The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus disease in three communities

1 reference

12 December 2020

10.2165/00019053-200725090-00004

Identifiers

DOI

1 reference

PubMed ID

17803334

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17803334